Accurate prognostication in congenital heart disease is vital for purposes of obtaining insurance, yet can be problematic for patients, physicians and insurers.
Mandating a fixed threshold will also have the perverse effect of lessening incentives to increase productivity in health care and get lower prices from insurers, physiciansand hospitals.